Cargando…
New PET/CT criterion for predicting lymph node metastasis in resectable advanced (stage IB‐III) lung cancer: The standard uptake values ratio of ipsilateral/contralateral hilar nodes
BACKGROUND: The aim of the present study was to use surgical and histological results to develop a simple noninvasive technique to improve nodal staging using preoperative PET/CT in patients with resectable lung cancer. METHODS: Preoperative PET/CT findings (pStage IB–III 182 patients) and pathologi...
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons Australia, Ltd
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8888156/ https://www.ncbi.nlm.nih.gov/pubmed/35048499 http://dx.doi.org/10.1111/1759-7714.14302 |
_version_ | 1784661074131288064 |
---|---|
author | Kameyama, Komei Imai, Kazuhiro Ishiyama, Koichi Takashima, Shinogu Kuriyama, Shoji Atari, Maiko Ishii, Yoshiaki Kobayashi, Akihito Takahashi, Shugo Kobayashi, Mirai Harata, Yuzu Sato, Yusuke Motoyama, Satoru Hashimoto, Manabu Nomura, Kyoko Minamiya, Yoshihiro |
author_facet | Kameyama, Komei Imai, Kazuhiro Ishiyama, Koichi Takashima, Shinogu Kuriyama, Shoji Atari, Maiko Ishii, Yoshiaki Kobayashi, Akihito Takahashi, Shugo Kobayashi, Mirai Harata, Yuzu Sato, Yusuke Motoyama, Satoru Hashimoto, Manabu Nomura, Kyoko Minamiya, Yoshihiro |
author_sort | Kameyama, Komei |
collection | PubMed |
description | BACKGROUND: The aim of the present study was to use surgical and histological results to develop a simple noninvasive technique to improve nodal staging using preoperative PET/CT in patients with resectable lung cancer. METHODS: Preoperative PET/CT findings (pStage IB–III 182 patients) and pathological diagnoses after surgical resection were evaluated. Using PET/CT images to determine the standardized uptake value (SUV) ratio, the SUV(max) of a contralateral hilar lymph node (on the side of the chest opposite to the primary tumor) was measured simultaneously. The I/C‐SUV ratio was calculated as ipsilateral hilar node SUV/contralateral hilar node SUV. Receiver operating characteristic (ROC) curves were then used to analyze those data. RESULTS: Based on ROC analyses, the cutoff I/C‐SUV ratio for diagnosis of lymph node metastasis was 1.34. With a tumor ipsilateral lymph node SUV(max) ≥2.5, an IC‐SUV ratio ≥1.34 had the highest accuracy for predicting N1/N2 metastasis; the sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV) and accuracy of nodal staging were 60.66, 85.11, 84.09, 62.5 and 71.29%, respectively. CONCLUSIONS: When diagnosing nodal stage, a lymph node I/C‐SUV ratio ≥1.34 can be an effective criterion for determining surgical indications in advanced lung cancer. |
format | Online Article Text |
id | pubmed-8888156 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | John Wiley & Sons Australia, Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-88881562022-03-04 New PET/CT criterion for predicting lymph node metastasis in resectable advanced (stage IB‐III) lung cancer: The standard uptake values ratio of ipsilateral/contralateral hilar nodes Kameyama, Komei Imai, Kazuhiro Ishiyama, Koichi Takashima, Shinogu Kuriyama, Shoji Atari, Maiko Ishii, Yoshiaki Kobayashi, Akihito Takahashi, Shugo Kobayashi, Mirai Harata, Yuzu Sato, Yusuke Motoyama, Satoru Hashimoto, Manabu Nomura, Kyoko Minamiya, Yoshihiro Thorac Cancer Original Articles BACKGROUND: The aim of the present study was to use surgical and histological results to develop a simple noninvasive technique to improve nodal staging using preoperative PET/CT in patients with resectable lung cancer. METHODS: Preoperative PET/CT findings (pStage IB–III 182 patients) and pathological diagnoses after surgical resection were evaluated. Using PET/CT images to determine the standardized uptake value (SUV) ratio, the SUV(max) of a contralateral hilar lymph node (on the side of the chest opposite to the primary tumor) was measured simultaneously. The I/C‐SUV ratio was calculated as ipsilateral hilar node SUV/contralateral hilar node SUV. Receiver operating characteristic (ROC) curves were then used to analyze those data. RESULTS: Based on ROC analyses, the cutoff I/C‐SUV ratio for diagnosis of lymph node metastasis was 1.34. With a tumor ipsilateral lymph node SUV(max) ≥2.5, an IC‐SUV ratio ≥1.34 had the highest accuracy for predicting N1/N2 metastasis; the sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV) and accuracy of nodal staging were 60.66, 85.11, 84.09, 62.5 and 71.29%, respectively. CONCLUSIONS: When diagnosing nodal stage, a lymph node I/C‐SUV ratio ≥1.34 can be an effective criterion for determining surgical indications in advanced lung cancer. John Wiley & Sons Australia, Ltd 2022-01-20 2022-03 /pmc/articles/PMC8888156/ /pubmed/35048499 http://dx.doi.org/10.1111/1759-7714.14302 Text en © 2022 The Authors. Thoracic Cancer published by China Lung Oncology Group and John Wiley & Sons Australia, Ltd. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. |
spellingShingle | Original Articles Kameyama, Komei Imai, Kazuhiro Ishiyama, Koichi Takashima, Shinogu Kuriyama, Shoji Atari, Maiko Ishii, Yoshiaki Kobayashi, Akihito Takahashi, Shugo Kobayashi, Mirai Harata, Yuzu Sato, Yusuke Motoyama, Satoru Hashimoto, Manabu Nomura, Kyoko Minamiya, Yoshihiro New PET/CT criterion for predicting lymph node metastasis in resectable advanced (stage IB‐III) lung cancer: The standard uptake values ratio of ipsilateral/contralateral hilar nodes |
title | New PET/CT criterion for predicting lymph node metastasis in resectable advanced (stage IB‐III) lung cancer: The standard uptake values ratio of ipsilateral/contralateral hilar nodes |
title_full | New PET/CT criterion for predicting lymph node metastasis in resectable advanced (stage IB‐III) lung cancer: The standard uptake values ratio of ipsilateral/contralateral hilar nodes |
title_fullStr | New PET/CT criterion for predicting lymph node metastasis in resectable advanced (stage IB‐III) lung cancer: The standard uptake values ratio of ipsilateral/contralateral hilar nodes |
title_full_unstemmed | New PET/CT criterion for predicting lymph node metastasis in resectable advanced (stage IB‐III) lung cancer: The standard uptake values ratio of ipsilateral/contralateral hilar nodes |
title_short | New PET/CT criterion for predicting lymph node metastasis in resectable advanced (stage IB‐III) lung cancer: The standard uptake values ratio of ipsilateral/contralateral hilar nodes |
title_sort | new pet/ct criterion for predicting lymph node metastasis in resectable advanced (stage ib‐iii) lung cancer: the standard uptake values ratio of ipsilateral/contralateral hilar nodes |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8888156/ https://www.ncbi.nlm.nih.gov/pubmed/35048499 http://dx.doi.org/10.1111/1759-7714.14302 |
work_keys_str_mv | AT kameyamakomei newpetctcriterionforpredictinglymphnodemetastasisinresectableadvancedstageibiiilungcancerthestandarduptakevaluesratioofipsilateralcontralateralhilarnodes AT imaikazuhiro newpetctcriterionforpredictinglymphnodemetastasisinresectableadvancedstageibiiilungcancerthestandarduptakevaluesratioofipsilateralcontralateralhilarnodes AT ishiyamakoichi newpetctcriterionforpredictinglymphnodemetastasisinresectableadvancedstageibiiilungcancerthestandarduptakevaluesratioofipsilateralcontralateralhilarnodes AT takashimashinogu newpetctcriterionforpredictinglymphnodemetastasisinresectableadvancedstageibiiilungcancerthestandarduptakevaluesratioofipsilateralcontralateralhilarnodes AT kuriyamashoji newpetctcriterionforpredictinglymphnodemetastasisinresectableadvancedstageibiiilungcancerthestandarduptakevaluesratioofipsilateralcontralateralhilarnodes AT atarimaiko newpetctcriterionforpredictinglymphnodemetastasisinresectableadvancedstageibiiilungcancerthestandarduptakevaluesratioofipsilateralcontralateralhilarnodes AT ishiiyoshiaki newpetctcriterionforpredictinglymphnodemetastasisinresectableadvancedstageibiiilungcancerthestandarduptakevaluesratioofipsilateralcontralateralhilarnodes AT kobayashiakihito newpetctcriterionforpredictinglymphnodemetastasisinresectableadvancedstageibiiilungcancerthestandarduptakevaluesratioofipsilateralcontralateralhilarnodes AT takahashishugo newpetctcriterionforpredictinglymphnodemetastasisinresectableadvancedstageibiiilungcancerthestandarduptakevaluesratioofipsilateralcontralateralhilarnodes AT kobayashimirai newpetctcriterionforpredictinglymphnodemetastasisinresectableadvancedstageibiiilungcancerthestandarduptakevaluesratioofipsilateralcontralateralhilarnodes AT haratayuzu newpetctcriterionforpredictinglymphnodemetastasisinresectableadvancedstageibiiilungcancerthestandarduptakevaluesratioofipsilateralcontralateralhilarnodes AT satoyusuke newpetctcriterionforpredictinglymphnodemetastasisinresectableadvancedstageibiiilungcancerthestandarduptakevaluesratioofipsilateralcontralateralhilarnodes AT motoyamasatoru newpetctcriterionforpredictinglymphnodemetastasisinresectableadvancedstageibiiilungcancerthestandarduptakevaluesratioofipsilateralcontralateralhilarnodes AT hashimotomanabu newpetctcriterionforpredictinglymphnodemetastasisinresectableadvancedstageibiiilungcancerthestandarduptakevaluesratioofipsilateralcontralateralhilarnodes AT nomurakyoko newpetctcriterionforpredictinglymphnodemetastasisinresectableadvancedstageibiiilungcancerthestandarduptakevaluesratioofipsilateralcontralateralhilarnodes AT minamiyayoshihiro newpetctcriterionforpredictinglymphnodemetastasisinresectableadvancedstageibiiilungcancerthestandarduptakevaluesratioofipsilateralcontralateralhilarnodes |